5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 4.44▲ | 4.45▼ | 4.43▲ | 4.45▲ | 4.69▼ |
MA10 | 4.44▲ | 4.42▲ | 4.44▲ | 4.60▼ | 3.98▲ |
MA20 | 4.41▲ | 4.41▲ | 4.39▲ | 4.71▼ | 3.23▲ |
MA50 | 4.42▲ | 4.46▼ | 4.45▲ | 3.75▲ | 3.85▲ |
MA100 | 4.38▲ | 4.53▼ | 4.79▼ | 3.13▲ | 25.10▼ |
MA200 | 4.42▲ | 4.77▼ | 4.24▲ | 3.50▲ | 69.93▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.010▲ | 0.014▲ | -0.117▼ | 0.380▲ |
RSI | 53.955▲ | 52.598▲ | 50.288▲ | 52.453▲ | 54.345▲ |
STOCH | 67.590 | 77.373 | 72.963 | 24.135 | 73.882 |
WILL %R | -34.783 | -17.778▲ | -17.778▲ | -78.049▼ | -36.056 |
CCI | 77.273 | 47.966 | 72.192 | -76.564 | 70.081 |
Monday, September 22, 2025 08:39 AM
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Adverum ...
|
Monday, September 22, 2025 08:24 AM
Adverum Biotechnologies (ADVM) announced it has notified sites that it plans to complete screening in ARTEMIS, its first pivotal Phase 3 trial evaluating Ixo-vec in wet age-related macular ...
|
Monday, September 22, 2025 01:00 AM
Screening closing ahead of expectations, with full enrollment now anticipated in 4Q 2025 (previously 1Q 2026) ARTEMIS topline data readout accelerated to 1Q 2027 REDWOOD CITY, Calif., Sept. 22, 2025 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
21/10/25 | 4.47 | 4.53 | 4.17 | 4.47 | 88,032 |
20/10/25 | 4.29 | 4.50 | 4.27 | 4.46 | 86,637 |
17/10/25 | 4.57 | 4.6184 | 4.2601 | 4.29 | 104,033 |
16/10/25 | 4.54 | 4.81 | 4.43 | 4.56 | 173,699 |
15/10/25 | 4.60 | 4.6522 | 4.25 | 4.48 | 177,636 |
14/10/25 | 4.18 | 4.6099 | 4.11 | 4.59 | 332,704 |
13/10/25 | 4.86 | 4.945 | 4.16 | 4.16 | 285,008 |
10/10/25 | 5.32 | 5.4253 | 4.75 | 4.81 | 269,752 |
09/10/25 | 4.87 | 5.59 | 4.85 | 5.32 | 390,252 |
08/10/25 | 4.93 | 4.97 | 4.72 | 4.88 | 170,045 |
|
|
||||
|
|
||||
|
|